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Abstract 
Thymosin beta-4 (Tβ4) is a member of beta-
thymosins, a family of small peptides involved
in polymerization of G-actin, and in many crit-
ical biological processes including apoptosis,
cell migration, angiogenesis, and fibrosis.
Previous studies in the newborn liver did not
reveal any significant reactivity for Tβ4 during
the intrauterine life. The aim of the present
study was to investigate by immunohistochem-
istry Tβ4 expression in the adult normal liver.
Thirty-five human liver samples, including 11
needle liver biopsies and 24 liver specimens
obtained at autopsy, in which no pathological
change was detected at the histological exam-
ination, were immunostained utilizing an
anti-Tβ4 commercial antibody. Tβ4 was detect-
ed in the hepatocytes of all adult normal livers
examined. A zonation of Tβ4 expression was
evident in the vast majority of cases.
Immunostaining was preferentially detected in
zone 3, while a minor degree of reactivity was
detected in periportal hepatocytes (zone 1). At
higher power, Tβ4-reactive granules appeared
mainly localized at the biliary pole of hepato-
cytes. In cases with a strong immunostaining,
even perinuclear areas and the sinusoidal pole
of hepatocytes appeared interested by
immunoreactivity for Tβ4. The current work
first evidences a strong diffuse expression of
Tβ4 in the adult human liver, and adds hepato-
cytes to the list of human cells able to synthe-
size large amounts of Tβ4 in adulthood.
Moreover, Tβ4 should be added to the liver pro-
teins characterized by a zonate expression pat-
tern, in a descending gradient from the termi-
nal vein to the periportal areas of the liver aci-
nus. Identifying the intimate role played by
this peptide intracellularly and extracellularly,
in physiology and in different liver diseases, is
a major challenge for future research focusing
on Tβ4. 
Introduction
Thymosin beta 4 (Tβ4) is a member of thy-
mosins,1 a versatile family of small peptides
expressed in most mammalian cells.2 It shows
a high intracellular concentration, in cells able
to rapidly increase their motility, like polymor-
phonuclear leukocytes, macrophages3,4 and
mast cells.5 There exist about 15 highly homol-
ogous β-thymosin variants, containing 40 to 44
amino acid residues, that are found not only
inside of cells but also in extracellular fluids,
such as blood serum,6 saliva,7 wound fluid,8
and lacrimal secretion.9 Among thymosin pep-
tides, Tβ4 is considered the most abundant in
mammalian tissues: its activity has been
mainly correlated with the regulation of actin
polymerization in living cells.10 Tβ4 is thought
to be also involved in many critical biological
processes including angiogenesis,11 wound
healing,12 inflammatory response13 and cell
migration.14 Similarly, Tβ4 activity was impli-
cated in differentiation of hematopoietic
cells,15 in carcinogenesis,16 in apoptosis,17 and
in blood coagulation.18
Recently, many authors have proposed the
Tβ4 involvement in the process of determining
fibrosis in different organs. In mice with
ureteral obstruction, Tβ4 has been shown to
have profibrotic effects, while its metabolite
Ac-SDKP showed anti-fibrotic actions.19 In
human hepatic stellate cells in culture, Tβ4
showed antifibrogenic effects, mediated by
upregulation of the expression of hepatocyte
grow factor (HGF) and by downregulation of
the expression of platelet-derived growth fac-
tor-β (PDGF-β) receptor.20 A recent study from
our group carried out on the human newborn
liver did not reveal any significant reactivity
for Tβ4 in the vast majority of liver cells during
gestation and at birth.21
On the basis of these data, and given the
previously reported ability of thymosins to
change their expression pattern at different
ages, it seemed of some interest to investigate
by immunohistochemistry the Tβ4 expression
pattern in the adult liver, in order to shed light
on the role played by liver cells in the synthesis
of this peptide. 
Materials and Methods
The study included archived paraffin-
embedded liver sections obtained from 35 sub-
jects. The cohort included 11 needle liver biop-
sies, performed on different clinical settings,
in which no sign of liver pathology was detect-
ed at the histological examination, and 24 liver
samples obtained in autopsy patients who died
for different extrahepatic aetiologies, in which
careful macroscopic and histological examina-
tion of liver sections did not evidence any sig-
nificant pathological change. The age of sub-
jects (24 males and 11 females) ranged from
29 up to 77 years. Clinical data at the basis of
the decision of performing liver biopsies are
reported in Table 1; the cause of death of the
24 autopsy cases is reported in Table 2. All liver
samples were routinely formalin-fixed and
paraffin-embedded. 
Staining of formalin-fixed, paraffin-embed-
ded 5 μm sections for Tβ4 was performed
essentially as previously described.5 Briefly,
slides were deparaffinized, rehydrated, and
endogenous peroxidase activity was quenced
(30 min) by 0.3% hydrogen peroxide in
methanol. Slides were then subjected to anti-
gen retrival by boiling (20 min) in 10 mM cit-
rate buffer, pH 6. Slides were incubated with
10% normal goat serum in phosphate
buffered saline (PBS) for 60 min to block non-
specific binding, followed by incubation (20 h,
4°C) with polyclonal anti-thymosin beta 4
antibody (Bachem-Peninsula Lab, San Carlos,
CA, USA) diluted 1:100 in blocking solution.
Slides were extensively washed with PBS con-
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taining 0.01% Triton X-100 and incubated
with a secondary reagent (Envision kit)
according to the manufacturer’s (Dako,
Glostrup, Denmark) instructions. After addi-
tional washes, color was developed using AEC
reagent (Dako), sections were counter-
stained with hematoxylin and mounted.
Immunostained specimens were examined by
two pathologists (GF, SN). A semiquantitative
grading system for the evaluation of Tβ4
immunoreactivity has been applied: + = focal
weak staining; ++ = diffuse weak staining;
+++ = diffuse strong staining. Zone 3
(periterminal hepatocytes) and zone 1 (peri-
portal hepatocytes) were independently ana-
lyzed for Tβ4 immunoreactivity.
Results
Tβ4 reactivity was detected in all normal
liver biopsies of adult subjects studied. No sig-
nificant difference was observed between
bioptic and autoptic liver examined. No rela-
tionship was found between the degree of Tβ4
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Table 1. clincal and immunohistochemical data of 11 liver needle biopsies characterized at histology by absent or minimal changes. 
+ = weak and focal; ++ = weak and diffuse; +++ = strong and diffuse.
Case n. Age Sex Clinical diagnosis Grade of Tß4 immunostaining Zone 3 Grade of Tß4 immunostaining Zone 1
1 40 M HCV + -
2 36 M HBV + HCV + -
3 67 F HBV + -
4 64 M HCV + -
5 27 M Cholestasis ++ +
6 38 F HCV + -
7 45 F HBV/HCV - -
8 53 M Suspicious for neoplasia ++ +
9 51 F Surrounding of FNH +++ ++
10 46 F Surrounding of adenoma ++ +
11 38 M HCV + -
Table 2. Clinical and immunohistochemical data regarding 25 liver samples obtained at autopsy, all characterized at histology by absent
or minimal changes. + = weak and focal; ++ = weak and diffuse; +++ = strong and diffuse.
Case n. Age Sex Clinical diagnosis Grade of Tß4 immunostaining Zone 3 Grade of Tß4 immunostaining Zone 1
1 83 M Heart attack +++ ++
2 59 M Heart attack +++ ++
3 62 F Cardiac Infarction ++ +
4 60 M Pneumonia ++  +
5 43 M Heart attack ++ +
6 73 F Heart attack ++ ++
7 31 M ++ +
8 32 M Pulmonary embolism ++ +
9 68 F Heart attack +/- -
10 50 M + -
11 45 F Haemopericardium + +
12 91 F Heart attack ++ +
13 81 M Aortic aneurism +++ ++
14 58 F Sepsis ++ +
15 71 F Respiratory insufficiency ++ +
16 49 M Heart attack +++ ++
17 61 M Pulmonary embolism ++ +
18 53 M Heart rupture + -
19 78 M Brain haemorrage ++ +
20 67 F Pulmonary embolism ++ +
21 80 F Brain haemorrage ++ -
22 47 M Pneumonia ++ +
23 75 M Intestinal infarct ++ +
24 53 F Post-haemorragic shock ++ +
25 49 M Heart attack ++ +
[European Journal of Histochemistry 2011; 55:e25] [page 133]
immunostaining and age or sex of the sub-
jects. Immunoreactivity for the peptide was
mainly localized in the cytoplasm of hepato-
cytes, appearing as large granules different in
shape and size. At low power, in the vast major-
ity of cases, immunoreactivity for Tβ4 was not
homogeneously diffuse to the entire parenchy-
ma: it was mainly stored in periterminal hepa-
tocytes (zone 3 of the acinus) while a minor
degree of reactivity was detected in periportal
hepatocytes (zone 1) (Figure 1). We often
detected a zonation of Tβ4 expression, charac-
terized by a progressive increase in the degree
of immunostaining from the periportal to the
periterminal areas, intermediate levels of Tβ4
immunostaining being observed in the hepato-
cytes of acinar zone 2. In some cases (see
Table 1 and Table 2), the periportal hepatocytes
did not show any reactivity for the peptide: in
these cases, only a mild reactivity for the pep-
tide was found in zone 3 liver cells, indicating
a strict correlation between Tβ4 storage in the
different acinar zones. The degree of reactivi-
ty changed from one case to the next. In some
cases only the periterminal hepatocytes were
reactive for the peptide (Figure 2), while in
other cases even periportal hepatocytes were
immunostained (Figure 3). Tβ4-reactive intra-
cytoplasmic granules appeared mainly local-
ized at the biliary pole of hepatocytes (Figure
4). In cases with a strong immunostaining,
even perinuclear areas and the sinusoidal pole
of hepatocytes appeared interested by Tβ4
overload (Figure 5). Even the size of Tβ4 gran-
ules changed from one case to the next, the
largest immunoreactive granules constantly
being observed in cases characterized by the
highest levels of reactivity for the peptide
(Figure 5). The vast majority of stored peptide
was constantly found inside the cytoplasm of
the hepatocytes, in the absence of significant
Tβ4 staining in Kupffer cells and in Ito cells. 
Discussion
For some decades from the discovery of Tβ4
in the calf thymus in 1965,22 researchers have
looked at its distribution in different organs
and tissues and asked, what does it mean? To
date, the majority of attempts to elucidate the
mechanism of action of Tβ4 in living organ-
isms has come from the perspective of physiol-
ogists, biochemists and biologists and, possi-
bly, have lacked an understanding of the role
played by this peptide in human health and
disease. 
To this date, at the best of our knowledge,
only one study from our group has investigated
Tβ4 expression in the human liver in new-
borns and during foetal development.21 In that
study, Tβ4 was not detected in liver cells, in
hepatocytes, in ductal cells and in oval cells of
the ductal plate, whereas low levels of expres-
sion were occasionally detected in isolated
cells inside the loose connective tissue of
immature portal tracts. These data were in
favour of a minor role of human liver in Tβ4
metabolism. On the contrary, the current work
evidences striking differences between the
adult human liver and the newborn liver as for
Tβ4 immunoreactivity. The two conditions, the
newborn and the adult, appear to represent the
extremes of a spectrum: complete absence of
the peptide in liver cells at birth, and a strong
diffuse accumulation in the hepatocytes in
some adults. 
It is unclear why this difference in the
amount of Tβ4 exists between adults and new-
borns, but our findings confirm previous
reports on the ability of Tβ4, as well of other
beta-thymosins, to change its expression dur-
ing life, both quantitatively and qualitatively.
In human salivary glands, we first showed a
decrease in the degree of Tβ4 expression from
the foetus and the newborn to adults.23
Moreover, we also showed a modification of
the protein expression pattern, which was
granular and mainly localized inside the acinar
lumen in newborns, while it appeared homoge-
neously diffuse to the entire cytoplasm in
adults.23 The granular reactivity was interpret-
ed as a secretory pattern, explaining the previ-
ously reported presence of large amounts of
Tβ4 in saliva of newborns;7 the weak homoge-
neous staining of the entire cytoplasm was
interpreted as a structural pattern, putatively
related to the G-actin binding activity of
Tβ4.2,20 The present study adds strenght to a
marked variability in the expression and func-
tion of Tβ4 in different organs, showing a com-
pletely opposite modification in the peptide
expression in the liver, characterized by the
Original paper
Figure 2. A strong Tβ4-imunoreactivity is
observed in the periterminal hepatocytes.
Scale bar: 400 µm.
Figure 3. A lower Tβ4-immunoreactivity is
detected in periportal hepatocytes. Scale
bar: 400 µm.
Figure 4. Tβ4-reactive intracytoplasmic
granules are localized at the biliary pole of
hepatocytes. Scale bar: 400 µm.
Figure 5. Tβ4-reactive granules with a per-
inuclear distribution in the hepatocytes are
detected. Tβ4 immunoreactivity at the
sinusoidal pole of the cytoplasm of the
hepatocytes is observed. Scale bar: 400 µm.
Figure 1. Tβ4 immunoreactivity is local-
ized in the periterminal hepatocytes. A
minor reactivity for the peptide is detected
in the periportal hepatocytes. Scale bar:
250 µm.
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absence of Tβ4 at birth and its impressive syn-
thesis in the adult.
The high intracellular concentration of Tβ4
observed in normal hepatocytes deserves some
consideration on the not well known activity of
this versatile peptide. The main intracellular
action of β-thymosins in resting cells has gen-
erally been considered their ability to
sequester monomeric actin, inhibiting its abil-
ity to polymerize and therefore removing it
from the cycling actin pool.24 During cell acti-
vation for cellular activities like locomotion,
actin monomers are rapidly desequestrated in
order to achieve the formation of actin fila-
ments.2 As a consequence, the intracellular
concentration of Tβ4 has been found to be par-
ticularly high in cells that rapidly respond to
external signals by profound shape changes
like platelets25,26 or by increased motility like
polymorphonuclear cells,27 mast cells5 and ma-
crophages.28,29 The observation in this study of
large amounts of Tβ4 in the hepatocytes, i.e. in
cells which do not rapidly change their shape
or their motility, clearly supports the hypothe-
sis that Tβ4 is not a simple actin monomer
binding protein.3 The massive hepatic Tβ4
expression described in this study in some
subjects, adds hepatocytes to the list of human
cells able to sinthesize large amounts of the
peptide in adulthood. The serum concentration
of free Tβ4 has been estimated to range from
0.45 up to 1.1 μg/L,6 which is very high when
compared to the concentration of insulin or
glucagon,2 but comparable to the adenosin
concentration.30 Such an high serum level of
Tβ4 in the steady state can not be explained by
its release by platelets during blood coagula-
tion24 or by leukocytes and monocytes during
inflammation.31 On the contrary, the present
work induces to hypothesize that the high
serum content of Tβ4 could, at least in part,
originate by hepatocytes. Further studies cor-
relating the hepatic Tβ4 expression pattern
with serum levels of the peptide will clarify the
role of liver cells in plasma Tβ4 levels. 
The preferential concentration of Tβ4 in the
hepatocytes of zone 3 of the liver acinus also
deserves some consideration. The descending
gradient from the terminal vein towards the
periportal areas indicate that the peptide is
mainly synthesized in zone 3 hepatocytes and,
only when major quantities of Tβ4 are needed,
even zone 2 and zone 1 hepatocytes are
recruited for its additional synthesis. A similar
zonation pattern, with high expression in the
downstream perivenous region, has ben
described for many liver enzymes, including
Cytochrome P-45032 and glutamine syn-
thetase.33 By comparison with our knowledge
on the acinar gradients of liver proteins, now
including Tβ4, much less is known about how
these gradients are formed, modified and
maintained. Different concentrations of oxy-
gen and of humoral factors have been proposed
to may create a gradient-type zonation pat-
tern.32 In recent years, a fundamental role in
mechanisms involved in patterning of liver
parenchyma has been attributed to mor-
phogens, including Wnt, β-catenin, and adeno-
matous polyposis coli gene.33 As for the gradi-
ent-type zonation observed in this study for
Tβ4, our data show a marked interindividual
variability, not only in the degree of expression
but even in the zonation pattern. This finding
suggests that the intensity of Tβ4 synthesis
and the slope of the gradient can vary. Diurnal
variations in the degree and in spatial expres-
sion have been reported for other liver
enzymes, including CYP7.34 The low levels of
Tβ4 expression in all liver biopsies from sub-
jects positive for HBV or HCV markers (Table
1) induces to hypothesize a possible role for
hepatitis-related viruses in down-regulating
Tβ4 synthesis in infected liver cells. 
In conclusion, interesting data emerge from
the analysis of Tβ4 expression in liver cells,
clearly indicating Tβ4 as one of the proteins
synthesized by hepatocytes in normal condi-
tions. Identifying the intimate role played by
this peptide intracellularly and extracellularly,
in physiology and in liver diseases, is a major
challenge for future research focusing on Tβ4
expression in the human liver in health and
disease.
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